What Matinas BioPharma Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 3 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 3 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Stern Adam K | 10% owner | Jul 10 | In/At-money Exercise · X | +630,335 | $0.35 | +$221K | 743,785 |
| Stern Adam K | 10% owner | Jul 10 | In/At-money Exercise · X | +344,710 | $0.35 | +$121K | 416,900 |
| Stern Adam K | 10% owner | Oct 31 | In/At-money Exercise · X | +92,100 | $0.64 | +$59.4K | 113,450 |
| Conrad Herbert J | Director | Jun 22 | Gift · G | +1,358,122 | — | — | 4,694,566 |
| Conrad Herbert J | Director | Jun 22 | Gift · G | −1,358,122 | — | — | 0 |
| Wikler Matthew | Director | Dec 31 | Grant / award · A | +7,859 | — | — | 290,472 |
| Wikler Matthew | Director | Sep 30 | Grant / award · A | +6,106 | — | — | 282,613 |
| Mannino Raphael J | Chief Scientific Officer | Sep 03 | Other Transaction · J | +462,150 | — | — | 1,919,715 |
| Conrad Herbert J | Director | Aug 04 | Gift · G | +494,622 | — | — | 3,336,444 |
| Conrad Herbert J | Director | Aug 04 | Gift · G | −494,622 | — | — | 0 |
| Conrad Herbert J | Director | Jul 07 | Gift · G | +1,280,917 | — | — | 2,841,822 |
| Conrad Herbert J | Director | Jul 07 | Gift · G | −1,280,917 | — | — | 1,358,122 |
| Wikler Matthew | Director | Jun 30 | Grant / award · A | +10,244 | — | — | 276,507 |
| Jabbour Jerome D | President and CEO | Jun 19 | Derivative Conversion · C | +30,000 | — | — | 840,011 |
| Jabbour Jerome D | President and CEO | Jun 19 | Other Transaction · J | +6,000 | — | — | 810,011 |
| Scibetta James S | Director | Jun 19 | Derivative Conversion · C | +24,000 | — | — | 649,958 |
| Scibetta James S | Director | Jun 19 | Other Transaction · J | +4,800 | — | — | 625,958 |
| Mannino Raphael J | Chief Scientific Officer | Jun 19 | Derivative Conversion · C | +20,000 | — | — | 1,457,565 |
| Mannino Raphael J | Chief Scientific Officer | Jun 19 | Other Transaction · J | +8,000 | — | — | 1,437,565 |
| Wikler Matthew | Director | Jun 19 | Derivative Conversion · C | +12,000 | — | — | 266,263 |
Loading...
